You are here: Welcome to the MPKB » Welcome to the MPKB » Marshall Protocol » Olmesartan (Benicar) » Patient response to olmesartan (Benicar)
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Last revisionBoth sides next revision
home:mp:olmesartan:response [10.13.2018] – [Decrease in inflammation] sallieqhome:mp:olmesartan:response [06.05.2019] – [Patient response to olmesartan (Benicar)] sallieq
Line 1: Line 1:
 ====== Patient response to olmesartan (Benicar)     ====== ====== Patient response to olmesartan (Benicar)     ======
 +
 +<relatedarticles> [[home:patients:grappling_uncertainty|Confronting uncertainty about the Marshall Protocol]],  [[home:physicians:concerns|Physicians' concerns and success rates for 5 Dx]], [[home:starting:physician:reluctant#specific_research|Independent research into Olmesartan]]</article>
 +
  
 Olmesartan (Benicar) has two actions. It palliates symptoms by reducing inflammation, and it activates the innate immune response. Patients who begin the Marshall Protocol (MP) may experience either, both, or neither. According to one rough estimate, 25% of patients who begin the MP experience immediate symptomatic relief when they begin the olmesartan blockade, about 25% feel no different, and the other 50% will experience some adjustment symptoms. Even for MP patients who have a minimal initial reaction to olmesartan, the medication almost always ultimately has strong antibacterial effects resulting in immunopathology. For olmesartan to be effective, it has to be [[dosing|dosed regularly]]: 40mg every 6-8 hours. Olmesartan (Benicar) has two actions. It palliates symptoms by reducing inflammation, and it activates the innate immune response. Patients who begin the Marshall Protocol (MP) may experience either, both, or neither. According to one rough estimate, 25% of patients who begin the MP experience immediate symptomatic relief when they begin the olmesartan blockade, about 25% feel no different, and the other 50% will experience some adjustment symptoms. Even for MP patients who have a minimal initial reaction to olmesartan, the medication almost always ultimately has strong antibacterial effects resulting in immunopathology. For olmesartan to be effective, it has to be [[dosing|dosed regularly]]: 40mg every 6-8 hours.
home/mp/olmesartan/response.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.